ACR Convergence 2023, the world’s premier rheumatology experience, was held Nov. 10–15 at the San Diego Convention Center. Attendees were inspired by lectures from Keynote speaker Avi Goldfarb, PhD, ARP Distinguished Lecturer Kaleb Michaud, PhD, and many, many more. Watch this page for complete coverage. Plus, explore our Psoriatic Arthritis and ANCA-Associated Vasculitis FocusRheums for research reviews, case reports and clinical articles on advances in the diagnosis and management of these conditions. And don’t forget to visit the ACR/ARP Abstracts website.
Focused Content
Psoriatic Arthritis FocusRheum
Explore our coverage of the top research in psoriatic arthritis and additional information presented at ACR Convergence 2023 and much more.
VIEWANCA-Associated Vasculitis FocusRheum
Review our collection of articles on anti-neutrophil cytoplasmic antibody-associated vasculitis, including information on GPA, MPA and EGPA.
VIEW
Previous ACR Meetings
- ACR Convergence 2022
- ACR Convergence 2021
- ACR Convergence 2020
- 2019 ACR/ARP Annual Meeting
- 2018 ACR/ARHP Annual Meeting
- 2017 ACR/ARHP Annual Meeting
- 2016 ACR/ARHP Annual Meeting
- 2015 ACR/ARHP Annual Meeting
- 2014 ACR/ARHP Annual Meeting
- 2010 ACR/ARHP Annual Scientific Meeting
- 2009 ACR/ARHP Annual Scientific Meeting
- 2008 ACR/ARHP Annual Scientific Meeting
- 2006 ACR Annual Meeting
Complete Coverage
Guideline for ILD in Systemic Autoimmune Rheumatic Diseases
SAN DIEGO—In a scientific session at ACR Convergence 2023, Sindhu Johnson, MD, PhD, and Dinesh Khanna, MD, MSc, discussed ACR’s new guideline on SARDs and ILD.
The Great Debate 2023
SAN DIEGO—Panelists at ACR Convergence 2023 debate the merits of IL-6 inhibitors vs. glucocorticoids for the initial treatment of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR).
Large Vessel Vasculitis
SAN DIEGO—The large vessel vasculitides, including Takayasu’s arteritis and giant cell arteritis, experienced a surge of interest at ACR Convergence 2023. Here, we highlight important points from 10 of the studies presented at this conference.
Trimethoprim Sulfamethoxazole Prophylaxis & Infections in Patients with GPA
SAN DIEGO—In their study, Effect of Trimethoprim Sulfamethoxazole Prophylaxis on Infections During Treatment of Granulomatosis with Polyangiitis with Rituximab: A Population-Based Study, Mendel et al. assessed the relationship between trimethoprim sulfamethoxazole (TMP-SMX) and infection in patients undergoing treatment for granulomatosis with polyangiitis (GPA). Background/Purpose Infections during treatment of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV)…
Reduced-Dose Glucocorticoids for GPA & Microscopic Polyangiitis
SAN DIEGO—In a study titled Real-Life Use of the PEXIVAS Reduced-dose Glucocorticoid Regimen in Granulomatosis with Polyangiitis and Microscopic Polyangiitis, Nagle et al. evaluated the efficacy and safety of the reduced-dose glucocorticoid regimen in a real-world setting. Background/Purpose Glucocorticoids (GCs) in combination with rituximab (RTX) or cyclophosphamide are the cornerstone of treatment for patients with…
Pediatric Clinical Year in Review: 2023
SAN DIEGO—Too many excellent pediatric rheumatology studies to squeeze into one talk? What a good problem to have. Dr. Ardoin first highlighted baricitinib in juvenile idiopathic arthritis.
Skin & Joints: Experts Discuss Advances in PsA
SAN DIEGO—The understanding of the microenvironment in which immune cells interact with stromal cells in the synovium of psoriatic arthritis (PsA) and rheumatoid arthritis (RA) is deepening, potentially giving clues for treatments. As this understanding improves, so does the appreciation for its astounding complexity, an expert said here in a session at ACR Convergence, which…
Where Viral Infections Meet Rheumatic Disease
SAN DIEGO—Viral infections are a common cause of acute arthritis and, in general, tend to be short lived and are not usually associated with significant articular inflammation. Due to the prevalence of various viral infections across the globe, any patient with signs of early inflammatory arthritis (i.e., symptoms that have not yet lasted six weeks) should be evaluated for a possible infectious etiology, said Dr. Leonard Calabrese in the Review Course at ACR Convergence 2023.
Rheumatic Disease & Reproductive Health
SAN DIEGO—In the Review Course at ACR Convergence 2023, Dr. Megan Clowse spoke on the subject of reproductive counseling for patients with rheumatic conditions, a topic that has been the focus of much of her research and scholarship.
Top Research in ANCA-Associated Vasculitis Presented at ACR Convergence 2023
SAN DIEGO—Vasculitis expert and former editor of The Rheumatologist, Dr. Philip Seo gives us his picks for the 10 most important abstracts in ANCA-associated vasculitis to come out of ACR Convergence 2023.